GCH1 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GCH1 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GCH1 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GCH1 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GCH1 Down.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000073969 - N-ethylmaleimide sensitive factor, vesicle fusing ATPase

Gene

ENSG00000137073 - ubiquitin associated protein 2

Gene

ENSG00000104894 - CD37 molecule

Gene

ENSG00000184113 - claudin 5

Gene

ENSG00000269404 - Spi-B transcription factor

Gene

ENSG00000204539 - corneodesmosin

Gene

ENSG00000184261 - potassium two pore domain channel subfamily K member 12

Gene

ENSG00000091664 - solute carrier family 17 member 6

Gene

ENSG00000170454 - keratin 75

  • Gene

    ENSG00000073969 - N-ethylmaleimide sensitive factor, vesicle fusing ATPase


  • Gene

    ENSG00000137073 - ubiquitin associated protein 2


  • Gene

    ENSG00000104894 - CD37 molecule


  • Gene

    ENSG00000184113 - claudin 5


  • Gene

    ENSG00000269404 - Spi-B transcription factor


  • Gene

    ENSG00000204539 - corneodesmosin


  • Gene

    ENSG00000184261 - potassium two pore domain channel subfamily K member 12


  • Gene

    ENSG00000091664 - solute carrier family 17 member 6


  • Gene

    ENSG00000170454 - keratin 75

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.